(Q44039298)

29 November 2017

A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

29 November 2017

0 references

inflammation

0 references

opportunistic infection

1 reference

5

Mamoru Watanabe

1 reference

29 November 2017

Makoto Naganuma

1

1 reference

29 November 2017

Reiko Kunisaki

series ordinal

2

1 reference

29 November 2017

Naoki Yoshimura

series ordinal

3

1 reference

29 November 2017

Yoshiaki Takeuchi

series ordinal

4

1 reference

29 November 2017

5 October 2012

1 reference

Journal of Gastroenterology

29 November 2017

1 reference

29 November 2017

48

1 reference

29 November 2017

5

1 reference

29 November 2017

595-600

1 reference

Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis

29 November 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0686-9

Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0686-9

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0686-9

Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0686-9

Lower doses of 6-mercaptopurine/azathioprine bring enough clinical efficacy and therapeutic concentration of erythrocyte 6-mercaptopurine metabolite in Japanese IBD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0686-9

Clinical practice. Management of newly diagnosed HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0686-9

Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0686-9

Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0686-9

Viral prophylaxis in organ transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0686-9

Prophylaxis of herpesvirus infections in immunocompetent and immunocompromised older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0686-9

Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-012-0686-9

Tolerance and effectiveness of anti–tumor necrosis factor α therapies in elderly patients with rheumatoid arthritis: A population-based cohort study

21 January 2018

1 reference

12 December 2020

Anti-TNFalpha therapy and vaccination of adults

1 reference

12 December 2020

Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD.

1 reference

12 December 2020

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

1 reference

12 December 2020

TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice

1 reference

12 December 2020

Incidence and characteristics of the 2009 influenza (H1N1) infections in inflammatory bowel disease patients.

1 reference

12 December 2020

Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis

1 reference

12 December 2020

Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: an observational study

1 reference

12 December 2020

Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.

1 reference

12 December 2020

10.1007/S00535-012-0686-9

Identifiers

DOI

1 reference

29 November 2017

1 reference